BOSTON SCIENTIFIC CORPORATION 8,750,000 Shares of 5.50% Mandatory Convertible Preferred Stock, Series A Underwriting AgreementUnderwriting Agreement • May 28th, 2020 • Boston Scientific Corp • Surgical & medical instruments & apparatus • New York
Boston Scientific Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 8,750,000 shares of 5.50% Mandatory Convertible Preferred Stock, Series A, with a liquidation preference of $100.00 per share (the “Mandatory Convertible Preferred Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 1,312,500 shares of Mandatory Convertible Preferred Stock (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”.
